Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 20, 2019
O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
Journal: Cancer cell
Published: August 16, 2017
O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.
Journal: Cancer cell
Published: June 03, 2016
Case report: paroxysmal cold hemoglobinuria presenting during pregnancy.
Journal: BMC hematology
Published: September 03, 2014
Showing 1-4 of 4
Last Updated: 09/26/2026